Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists

February 23, 2023 updated by: University Ghent

Role of Pharmacists in Suicide Prevention: Needs Assessment Among Pharmacists

This study aims to examine the opinions and needs of pharmacists and pharmaceutical technical assistants (FTA) concerning their role as gatekeepers in suicide prevention.

The primary objective is to map the experiences and needs of (public) pharmacists and FTA with regard to suicide prevention.

The secondary objective is to be able to develop more targeted tools, interventions or trainings based on the results of the needs assessment in order to facilitate the role of (public) pharmacists and FTA as gatekeepers in suicide prevention.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

118

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Belgium
      • Ghent, Belgium, 9000
        • Flemish Centre of Expertise in Suicide Prevention, Ghent University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Dutch-speaking Belgian public pharmacists or pharmaceutical technical assistants (FTA)

Description

Inclusion Criteria:

  • Working as a (public) pharmacist or pharmaceutical technical assistant (FTA)
  • 18 years or older
  • Access to a computer, tablet or mobile phone with internet access
  • Dutch-speaking

Exclusion Criteria:

  • Hospital pharmacists or industrial pharmacists are not included in this study and thus constitute an exclusion criterion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Pharmacists and pharmaceutical technical assistants (FTA)
Dutch-speaking Belgian public pharmacists or pharmaceutical technical assistants (FTA)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Needs
Time Frame: Baseline. Completing the questionnaire will take approximately 15-20 minutes.

Questionnaire based on a study by Gillette et al. (2020), scientific literature and previous needs surveys conducted by VLESP. In collaboration with the Flemish Pharmacists Network.

Socio-demographics; Perceptions, attitudes and barriers: 55 statements (completely disagree, disagree, neutral, agree, completely agree); Contact with suicidal person (never/rarely, few times a year, monthly, weekly, daily), experience (very un-, rather un-, neutral, experienced, very experienced), possible actions as gatekeeper, referral, known organizations/helplines, previous education (yes or no), knowledge (yes/no)/ satisfaction (not at all, rather not, neutral, rather, very) existing education; Preparedness/need training (not at all, rather not, neutral, rather, very), preferred format of training, needed information; Suicidal thoughts/attempts (yes/no), hopelessness: 4 items (true/false)
Baseline. Completing the questionnaire will take approximately 15-20 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 2, 2022

Primary Completion (Actual)

December 8, 2022

Study Completion (Actual)

December 8, 2022

Study Registration Dates

First Submitted

October 11, 2022

First Submitted That Met QC Criteria

October 11, 2022

First Posted (Actual)

October 14, 2022

Study Record Updates

Last Update Posted (Actual)

February 24, 2023

Last Update Submitted That Met QC Criteria

February 23, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ONZ-2022-0233

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicidal Ideation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe